EXAS vs SUN · rev $2.76B vs P/E 16, rev $22.69B
EXACT Sciences Corporation (EXAS) versus Sunoco LP (SUN) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Sunoco LP (SUN) is a oil & gas refining & marketing company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported SUN revenue for 2024-12-31 was $22.69B. Net income was $874.0M. Revenue was down 1.6% from 2023-12-31 to 2024-12-31. SUN currently screens at market cap $11.84B and trailing P/E 16.0.
EXAS currently screens at market cap $20.03B. SUN currently screens at market cap $11.84B and trailing P/E 16.0.
Not investment advice. Open the EXAS and SUN stock pages for the full models.
Not investment advice.